March 13, 2018:

    This report studies the Global Orphan Drugs Market, analyzes and researches the development status and Top Players, Research Methodology, Research Process, Macroeconomic Indicators, Threat of New Entrants and Forecast to 2022

    Global Orphan Drugs Market has been segmented on the basis of pharmacological class, applications, technology, source and region.

    Global Orphan Drugs Market – Overview

    The Global orphan drugs market is growing exponentially owing to unmet needs for rare diseases and the growing investment in research and development are the major factor driving the orphan drugs Market.

    Key Players for Global Orphan Drugs Market:

    Hoffmann- La Roche, Celgene Corporation, Alexion Pharmaceuticals, Inc., Novartis AG, Takeda Pharmaceuticals Company Limited, Biogen Idec Limited, and Eli Lilly, Bristol-Myers Squibb, Vertex pharmaceuticals, Inc. Bayer AG, Sanofi, and Johnson & Johnson.

    The global orphan drug market was estimated to be $93 billion in 2015 and is projected to reach $200 billion by 2022. Orphan drugs, represented 35% of the industry’s new drug approvals. The orphan drugs are disorders that affects a small percentage of the population. The major driving factor for the growth are low marketing cost, extensive exclusivity, government support leading to economic, legislative and tax benefits, new technology development such as hybridoma, gene mapping, and DNA recombinant.

    Get Sample copy @ https://www.marketresearchfuture.com/sample_request/2312 .

    Global Orphan Drugs Market – Regional Analysis

    Depending on geographic region, Globally North America is the largest market for orphan drugs. Factors such as high product demand and the increasing government incentives are expected to promote market growth in the US region, which is considered to be the highest revenue-generating region in the Americas.

    Europe is the second-largest market for Global orphan drugs. The future market for orphan drugs is anticipated to be dominated by the developed regions with developing regions act as a supporting pillar to its growth.

    Asia Pacific will be the fastest growing regional market and is likely to be the key to the future. Middle East & Africa is expected to have limited but steady growth in the market.

    Global Orphan Drugs Market – Company Analysis

    This market is highly fragmented and is dominated by five major vendors including Bristol-Mayer Squibb Company, Celgene Corporation, F. Hoffmann La Roche, Novartis AG, and Pfizer Inc. as they have extensive product portfolios. Factors such as the high regulatory barriers, patent expiry of branded drugs, stringent rules and regulations, and decreased R&D productivity, pose significant challenges to the vendors during the forecast period.

    Other prominent players in the value chain include AstraZeneca plc, AbbVie Inc., Aegerion Pharmaceuticals, Inc., GlaxoSmithKline plc, Vertex Pharmaceuticals, Merck & Co., Inc., Boehringer Ingelheim GmbH, Amgen Inc., and Actelion Pharmaceuticals Ltd.

    Get Discount @ https://www.marketresearchfuture.com/check-discount/2312 .

    About Market Research Future:

    At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

    Contact

    Market Research Future

    Office No. 528, Amanora Chambers

    Magarpatta Road, Hadapsar,

    Pune – 411028

    Maharashtra, India

    +1 646 845 9312

    Email: sales@marketresearchfuture.com

    Source: http://heraldkeeper.com/